Treatment Resistent Cancers
Targeted Cancer Therapies
Targeted Cancer Therapies
Treatment Resistant Cancers
Cancer Therapies
Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 9, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
Neoadjuvant systemic treatment (NST) is vital for clinical trials, but pathological complete response (pCR) is a late indicator of efficacy. New early predictors are needed to optimize breast cancer treatment strategies.
Area of Science:
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025